1-(Methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl)but-3-yn-2-one (3a) reacted with 3-amino-1H-1,2,4-triazole and 5-aminopyrazole-4-carboxylic acid derivatives in the presence of base to furnish the triazolo [1,5-a]pyrimidine (5) 
Introduction
Iso-or "reversed" nucleosides represent a class of nucleoside analogues in which the nucleobase is linked to the sugar moiety with a carbon atom other than C-1. The syntheses of isonucleosides are interesting because compounds having anticancer and antiviral activities can result [1, 2] . Examples of such nucleosides are relatively rare in the literature but, in the recent years intensified activities could be observed on this field [3, 4] . Like C-nucleosides [5 -7] also iso-C-nucleosides show often different biological activities frequently caused by their increased hydrolytic and enzymatic stability [8, 9] . Furthermore, nucleoside derivatives possessing a heteroatom or a methylene group as spacer between the sugar unit and the heterocycle have been syn-0932-0776 / 05 / 1100-1175 $ 06.00 c 2005 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com thesized [10, 11] . In this paper we report the synthesis of spacered pyridine-, pyrazolo [1-5a] pyrimidine-, [1, 2, 4] triazolo [1,5-a] pyrimidine-and benz [4, 5] imidazo[1,2-a]pyridine-iso-C-nucleoside analogues from 1-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl)but-3-yn-2-ones (3).
Results and Discussion
Recently, we have described the synthesis of the 1-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl)but-3-yn-2-ones (3a and 3b) in five reaction steps from 2,3-anhydro-4,6-O-benzylidene-α-D-mannopyranoside 1 with the (pyranosid-3-yl)ethanal 2 as an intermediate (Scheme 1) [12] . These acetylenic ketones can be used as valuable synthetic intermediates for the preparation of nitrogen heterocycles. In order to prepare fused heterocyclic compounds having a spacered monosaccharide unit, ynone 3a was refluxed with 3-amino-1H-1,2,4-triazole in ethanol to furnish (3E)-4-(5-amino-1H-1,2,4-triazol-1-yl)-1-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-Daltropyranosid-3-yl)-3-buten-2-one (4) as an addition product in 55% yield (Scheme 2). As expected, for the compound 4 no signals of the acetylenic carbon atoms were observed in the 13 C NMR spectrum, but resonances were visible belonging to the triazole ring (at δ = 151.4 for C-3" and δ = 155.6 for C-5", respectively). In the 1 H NMR spectrum besides the signals of the sugar part, the signals of the NH 2 group and 3-H" at δ = 5.40 and δ = 7.49, respectively, were found. A large coupling constant (J = 13.0 Hz) for the coupling between 3-H and 4-H confirmed the (E)-configuration of the addition product.
Subsequent treatment of enone 4 with sodium ethanolate at room temperature led to the desired spacered triazolo [1,5-a] pyrimidine-iso-C-nucleoside 5 in 78% yield. The absence of the carbonyl and the amino signals in the IR and NMR spectra clearly demonstrated the successful course of the cyclization reaction. Moreover, the molecular peak at m/z = 488 and the 1 H NMR signals of 6-H, 2-H and 7-H at δ = 6.61, 8.40 and 8.44, respectively, with the coupling between 6-H and 7-H (J = 7.0 Hz) confirmed the structure of 5.
Reaction of compound 5 with aqueous acetic acid afforded the 5-(methyl 2-O-benzyl-3-deoxy-α-Daltropyranosid-3-yl-methyl) [1, 2, 4] triazolo [1,5-a] pyrimidine (6) in 92% yield. Unfortunately, attempts to split off the benzyl group in compound 6 by catalytic hydrogenation or with iodotrimethylsilane [13, 14] , respectively, under several conditions were unsuccessful.
Similarly, polycyclic spacered iso-C-nucleosides could be obtained by reaction of ynone 3a with various 5-aminopyrazole-4-carboxylic acid derivatives in ethanol under reflux followed by treatment with sodium ethanolate at room temperature to afford 2-amino-5-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl-methyl)pyrazolo-[1,5-a]pyrimidine-3-carboxylic acid derivatives 8a -d in good yields (Scheme 3). In the first step of this reaction as intermediates the 5-amino-3-(amino and 4-methoxyphenylamino, respectively)-1-[(1E)-4-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl)-3-oxo-1-butenyl]-1H-pyrazole-4-carboxylic acid derivatives 7 were formed. Compounds 7a, b were isolated in a pure form and completely characterized. In the 1 H NMR spectra of 7a and 7b the signals for 1'-H (7a: δ = 7.85, 7b: δ = 8.08) and 2'-H (7a: δ = 6.54, 7b: δ = 6.41) and the coupling constants 3 J 1 ,2 = 12.8 Hz and 13.2 Hz, respectively, proved that the addition of the 5-amino-pyrazole-4-carboxylic acid derivatives to the ynone 3a yielded compounds 7a, b in the (E)-configuration. Additionally, no signals of acetylenic carbon atoms were observed in the 13 C NMR spectra.
The 13 C NMR spectra of compounds 8a -d showed no signals for a carbonyl group. In addition, the expected molecular peaks and the 1 H NMR signals of 6-H and 7-H in the range of δ = 6.45 − 6.62 and δ = 8.04 − 8.24, respectively, with the coupling constants between 6-H and 7-H of J = 5.0 − 7.0 Hz confirmed the structures of the compounds 8.
On compound 8d deprotection was examined exemplarily. The cleavage of the benzylidene group could be performed in a mixture of acetic acid and water to provide the 2-amino-N-benzyl-5-(methyl 2-O-benzyl-3-deoxy-α-D-altropyranosid-3-y l-methyl) pyrazolo[1,5-a]pyrimidine-3-carboxamide (9) in 73% yield. Furthermore, the 2-O-benzyl group of compound 9 was removed by catalytic transfer hydrogenation using 10% palladium on carbon and ammonium formate as the hydrogen donor providing the iso-C-nucleoside 10 as a white solid in 79% yield. The values of 8.0 -8. 5 Hz for the coupling constants 3 J 4 ,5 for compounds 9 and 10 indicated an axial-axial disposition of 4'-H and 5'-H. This observation and the small values of 3 J 1 ,2 and 3 J 2 ,3 (∼ 2 − 5 Hz) in compounds 9 and 10 were strong clues that the 4 C 1 conformation had been retained.
Treatment of acetylenic ketone 3b with cyanacetamide, 2-cyano-N-(4-methoxyphenyl)acetamide, 3-oxo-N-phenyl-butyramide und N-(4-methoxyphenyl)-3-oxo-butyramide in the presence of potassium carbonate and 18-crown-6 provided the substituted 1,2-dihydropyridin-2-ones 11a -d in yields of 44 -77% (Scheme 4). In order to verify the regiochemistry of the reactions, NOESY spectra were measured. For 11b a correlation was observed between ortho-protons of phenyl at N-1 and the methylene spacer. In the NOESY spectra of compounds 11c, d cross peaks were found not only between the ortho protons of aryl at N-1 with the exocyclic methylene group but also between the acetyl group and the ortho-protons of the 4-phenyl ring. According to these results, the nucleophilic attack of the carbanionic carbon atom arising from the used carboxamides occurred at C-4 of ynone 3b and was followed by cyclization through attack of the amide nitrogen atom on the carbonyl group. All the other spectroscopic data including mass spectra were in accordance with the proposed structures.
The deprotection of compound 11d by treatment with aqueous acetic acid afforded the 3-acetyl-1,2-dihydro-1-(4-methoxyphenyl)-6-(methyl 2-O-benzyl-3-deoxy-α-D-altropyranosid-3-yl-methyl)-4-phenylpyridin-2-one (12) mixture of products, which could not be separated. The NMR spectra of the mixture showed that the removal of the benzyl group along with the reduction of the acetyl group at pyridone ring took place.
Similarly, the ynone 3b was allowed to react with 2-benzimidazolyl-acetonitrile in the presence of potassium carbonate and 18-crown-6 in order to synthesize 3-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl-methyl)-1-phenylbenz [4, 5] imidazo[1,2-a]pyridine-4-carbonitrile (13) which could be isolated as an amorphous dark yellow solid in 57% yield (Scheme 5). In dependency on the preferred direction of attack of the 2-benzimidazolylacetonitrile on the ynone isomers 13 and 14 could be formed. In a NOESY experiment of the isolated compound the expected cross peaks were found for the ortho protons of the 1-phenyl ring with 2-H and 9-H. These ortho hydrogen atoms showed different chemical shifts indicating a hindered rotation of the phenyl ring around the bond axis. A HMBC spectrum of 13 allowed the assignment of all 13 C NMR signals.
Experimental Section

General procedures
Solvents were distilled and, if necessary, dried using standard procedures. Melting points were measured with a Boëtius apparatus and are corrected. Specific rotations were determined with a Gyromat HP (Dr. Kernchen Ltd.). IR spectra were recorded with a Nicolet 205 FT-IR spectrometer. 1 H NMR (500.13, 300.13 and 250.13 MHz, respectively) and 13 C NMR (125.7, 75.5 MHz and 62.9 MHz) spectra were recorded on Bruker instruments AVANCE 500, ARX 300 and AC 250. The calibration of spectra was carried out on TMS (internal 1 H) and on solvent signals CDCl 3 :
The 13 C NMR signals were assigned by DEPT and/or twodimensional 13 C, 1 H correlation spectra. HMBC spectra were recorded for the compounds 8d, 11c and 13 in order to assign the quaternary carbon signals. The two-dimensional NOESY spectra for structure elucidation of 11a -d and 13 were recorded with an AVANCE 500 spectrometer using a mixing time of 1 sec. The mass spectra were measured on an AMD 402/3 spectrometer (AMD Intectra GmbH). For chromatography, Merck silica gel 60 (230 -400 mesh) was used. TLC was performed on silica gel 60 GF 254 (Merck) with detection by using UV-light and charring with sulfuric acid. Elemental analysis were performed on a CHNS automatic elemental Flash EA 1112 (ThermoQuest).
(3E)-4-(5-Amino-1H-1,2,4-triazol-1-yl)-1-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl)-3-buten-2-one (4)
A mixture of 3a (0.210 g, 0.5 mmol), 3-amino-1H-1,2,4-triazole (0.050 g, 0.6 mmol) and ethanol (5 ml) was heated under reflux for 4 h. The solvent was removed under reduced pressure and the residue was purified by column chromatography (EtOAc). Yield 0.140 g (55%), white solid. 
5-(Methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-Daltropyranosid-3-yl-methyl)-[1,2,4]triazolo[1,5-a]pyrimidine (5)
Compound 4 (0.253 g, 0.5 mmol) was added to a solution of sodium ethanolate (1.5 mmol) in ethanol (5 ml) and the mixture stirred for 1 h. After neutralization with amberlite IR-120 (Fluka-Chemie GmbH) the solvent was removed under reduced pressure and the residue was purified by column chromatography (toluene/ [1, 2, 4] triazolo [1,5-a] pyrimidine (6) A solution of compound 5 (0.245 g, 0.5 mmol) in acetic acid (5 ml) and water (0.5 ml) was heated at 70 • C for 5 h. Water (10 ml) and NaHCO 3 were added until neutralization of the solution. The mixture was extracted with EtOAc (3 × 50 ml), the organic phases were washed with water (2 × 50 ml), dried (Na 2 SO 4 ) and evaporated under reduced pressure. 
5-(Methyl 2-O-benzyl-3-deoxy-α-D-altropyranosid-3-ylmethyl)
5-Amino-3-(4-methoxyphenylamino)-1-[(1E)-4-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl)-3-oxo-but-1-enyl]-1H-pyrazole-4-carbonitrile (7a)
The reaction of 3a (0.210 g, 0.5 mmol) with 5-amino-3-(4-methoxyphenylamino)-1H-pyrazole-4-carbonitrile (115 mg, 0.5 mmol) prepared according to lit. [15, 16] was carried out as described above for the preparation of 4. 
3,5-Diamino-1-[(1E)-4-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl)-3-oxo-but-1-enyl]-1H-pyrazole-4-carboxamide (7b)
The reaction of 3a (0.210 g, 0.5 mmol) with 3,5-diamino-1H-pyrazole-4-carboxamide (70 mg, 0.5 mmol) [15, 16] was carried out as described above for the preparation of 4. 
2-(4-Methoxyphenyl)-5-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl-methyl)pyrazolo-[1,5-a]pyrimidine-3-carbonitrile (8a)
M e t h o d A :
The reaction of 7a (0.162 g, 0.25 mmol) with a solution of sodium ethanolate (1.5 mmol) in ethanol (5 ml) was carried out as described above for the preparation of 5.
M e t h o d B :
A mixture of 3a (0.210 g, 0.5 mmol), 5-amino-3-(4-methoxyphenylamino)-1H-pyrazole-4-carbonitrile (115 mg, 0.5 mmol) [15, 16] and ethanol (5 ml) was heated under reflux for 4 h. After cooling to 20 • C, the mixture was treated with sodium ethanolate (1.5 mmol) in ethanol (5 ml) for 1 h under stirring. Neutralization with amberlite IR-120 (FlukaChemie GmbH) was followed by evaporation of the solvent under reduced pressure and purification of the residue by column chromatography (toluene/EtOAc 6:1).
Yield 
2-Amino-5-(methyl-2-O-benzyl-4,6-O-benzylidene-3-deoxy-
Compound 7b (0.140 g, 0.25 mmol) was reacted as described above under method A for the preparation of 8a.
M e t h o d B :
Compound 3a (0.210 g, 0.5 mmol) and 3,5-diamino-1H-pyrazole-4-carboxamide (70 mg, 0.5 mmol) [15, 16] were reacted as described above under method B for the preparation of 8a. Yield 0.120 g (88%, method A), 0.220 g (82%, method B), white solid. 79 (m, 1H, H-3' ). - 13 C-7), 129.1,  128.2, 127.8, 127.7, 126.1 (o-, m-, p-Ph) , 108.7 (C-6), 101.9 (CH-Ph), 100.2 (C-1'), 87.3 (C-3), 75.8 (C-4' ), 74.6 (C-2'), 71.5 (CH 2 
Ethyl 2-(4-chlorophenylamino)-5-(methyl-2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl-methyl)-pyrazolo[1,5-a]pyrimidine-3-carboxylate (8c)
The reaction of 3a (0.210 g, 0.5 mmol) with ethyl 5-amino-3-(4-chlorophenylamino)-1H-pyrazole-4-carboxylate (140 mg, 0.5 mmol) [15, 16] was carried out as described above under method B for the preparation of 8a. 
2-Amino-N-benzyl-5-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl-methyl)pyrazolo[1,5-a]-pyrimidine-3-carboxamide (8d)
The reaction of 3a (0.210 g, 0.5 mmol) with 3,5-diamino-N-benzyl-1H-pyrazole-4-carboxamide (115 mg, 0.5 mmol) [15, 16] 
2-Amino-N-benzyl-5-(methyl 2-O-benzyl-3-deoxy-α-Daltropyranosid-3-yl-methyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (9)
The deprotection of compound 8d (0.315 g, 0.5 mmol) was carried out as described above for the preparation of 6 (reaction time 7 h). -N-benzyl-5-(methyl 3-deoxy-α-D-altropyranosid-3-yl-methyl) pyrazolo [1,5-a] pyrimidine-3-carboxamide (10) A mixture of 9 (0.135 g, 0.25 mmol), ammonium formate (0.1 g), 10% palladium on carbon (0.200 g, Lancaster) in dry MeOH (10 ml) was refluxed for 2 h. The catalyst was filtered off and washed with the solvent. The filtrate was evaporated under reduced pressure and the residue was purified by column chromatography (EtOAc/ 
2-Amino
1,2-Dihydro-6-(methyl 2-O-benzyl-4,6-O-benzylidene-3-deoxy-α-D-altropyranosid-3-yl-methyl)-2-oxo-4-phenylpyridine-3-carbonitrile (11a)
A mixture of 3b (0.250 g, 0.5 mmol), cyanacetamide (0.063 g, 0.75 mmol), K 2 CO 3 (0.120 g, 0.87 mmol), 18-crown-6 (100 mg, 0.38 mmol) in THF (15 ml) was refluxed up to the disappearance of 3b (8 h, TLC control). The suspension was filtered and the filtrate was concentrated. 
